Evaluation of anticoagulation re-initiation practices following reversal of factor Xa inhibitors with andexanet alfa or 4F-PCC in patients with major bleeding events by Awatif Hafiz, Alshaya Abdulrahman I, Katelyn W. Sylvester, Jean M. Connors, Jessica Rimsans

Get full text

What the near Future Holds for Sacubitril/Valsartan: A Summary of Major Ongoing Studies by Hisham A. Badreldin, Nasser Aldosari, Lama Alnashwan, Taif Almutairi, Nada Yousif, Khalid Alsulaiman, Ohoud Aljuhani, Awatif Hafiz, Omar Alshaya

Get full text

Comparison between standard Vs. Escalated dose venous thromboembolism (VTE) prophylaxis in critically ill patients with COVID-19: A two centers, observational study by Ohoud Aljuhani, Khalid Al Sulaiman, Awatif Hafiz, Khalid Eljaaly, Aisha Alharbi, Rahmah Algarni, Sarah Al Homaid, Khawla Kahtani, Tareq Alsulaiman, Ramesh Vishwakarma, Ghassan Al Ghamdi, Mai Alalawi, Ghazwa B. Korayem

Get full text

Statins and Risk of Thrombosis in Critically ill Patients with COVID-19: A Multicenter Cohort Study by Shmeylan Al Harbi, Raed Kensara, Ohoud Aljuhani, Ghazwa B. Korayem, Ali F. Altebainawi, Abdullah Al Harthi, Ramesh Vishwakarma, Alaa M. Alenazi, Abdulmajed Almutairi, Omar Alshaya, Sultan Alraddadi, Tareq Al Sulaiman, Latifah Aldakkan, Reem Mahboob, Kholoud Alaamer, Abdulrahman Alissa, Awatif Hafiz, Nada Aldhayyan, Sara Althewaibi, Farhan Alenezi, Nadeen Y. Alkhotani, Sara A. Alghamdi, Abeer A. Alenazi, Khalid Al Sulaiman

Get full text

Standard dosing of enoxaparin versus unfractionated heparin in critically ill patient with COVID-19: a multicenter propensity-score matched study by Khalid Al Sulaiman, Ohoud Aljuhani, Ghazwa B. Korayem, Awatif Hafiz, Mai Alalawi, Hisham A. Badreldin, Ali F. Altebainawi, Ramesh Vishwakarma, Abdulrahman Alissa, Albandari Alghamdi, Abeer A. Alenazi, Huda Al Enazi, Shahad Alanazi, Abdullah Alhammad, Jahad Alghamdi, Mashael AlFaifi, Faisal A. Al Sehli, Maram A. Aldossari, Alaa A. Alhubaishi, Anfal Y. Al-Ali, Hasan M. Al-Dorzi

Get full text

Thromboprophylaxis in Hospitalized Non-Critically Ill Patients With Mild-to-Moderate COVID-19 Infection: A Systematic Review and Meta-Analysis by Awatif Hafiz PharmD, BCCP, Hadeel Alkofide PhD, Khalid Al Sulaiman BCCCP, BCNSP, MBA, FCCM, Hala Joharji PharmD, BCPS, BCMTM, Sarah Aljohani PharmD, BCPS, Khadijah A. Sarkhi PharmD, Reem Alharbi PharmD, Ghazwa B. Korayem PharmD, BCPS, Mashael AlFaifi PharmD, BCPS, Samiah Alsohimi PharmD, Ohoud Aljuhani PharmD

Get full text

Evaluation of Apixaban in Patients With Antiphospholipid Syndrome: A Case Series and Review of Literature by Khalid Al Sulaiman SCC-CCP, BCCCP, BCNSP, MBA, Awatif Hafiz PharmD, BCCP, Hisham A. Badreldin PharmD, FCCP, BCPS, BCCP, Ghazwa B. Korayem PharmD, BCPS, Faisal Alsuwayyid PharmD, Abdulrahman Alrashidi, PharmD, Mohammed Alhijris PharmD, Faisal Almutairi, PharmD, Fahad Alharthi PharmD, Saad Alghamdi PharmD, Ahmed Abu Alreesh ClinPharmM.Sc, Ohoud Aljuhani PharmD, BCCCP

Get full text

Incidence and Clinical Outcomes of New-Onset Atrial Fibrillation in Critically Ill Patients with COVID-19: A Multicenter Cohort Study by Raed Kensara BSc.Pharm, SCC-CCP, BCPS, Ohoud Aljuhani PharmD, Ghazwa B Korayem PharmD, Hadeel Alkofide PhD, Sumaya N Almohareb PharmD, Yousef S Alosaimi PharmD, Ali F Altebainawi PharmD, Khalid Bin saleh PharmD, Norah Al Andas PharmD, MClinPharm, Shmeylan Al Harbi PharmD, Abdullah F Al Harthi PharmD, BCCCP, Uhood Ashkan PharmD, Rema Alghamdi PharmD, Hisham A Badreldin PharmD, Awatif Hafiz PharmD, Mashael AlFaifi PharmD, Rahaf A Alqahtani PharmD, Ramesh Vishwakarma PhD, Abeer A Alenazi PharmD, Mai Alalawi PharmD, Reem mahboob BSc.pharm, Renad A Alfouzan PharmD, Layan B Al Tuhayni PharmD, Nouf Al Qahtani BSc.pharm, MSc Med. Ed, Khalid Al Sulaiman BCCCP, BCNSP, MBA, FCCM

Get full text